Clinical and economic assessment of using IRS®19 for the treatment and prevention of acute respiratory infections in children
Objective: to perform pharmacoeconomic analysis of the feasibility of using topical bacterial lysate in the form of nasal spray (IRS®19) for the treatment and prevention of upper respiratory tract infections in pediatric population in comparison with other drugs registered in Russia, belonging to th...
Saved in:
| Main Authors: | A. S. Kolbin, A. R. Kasimova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2024-08-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/1036 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and economic assessment of using topical bacterial lysate Imudon® for the treatment and prevention of acute upper respiratory tract infections in children
by: A. R. Kasimova, et al.
Published: (2024-08-01) -
The use of bacterial lysate OM-85 in the treatment of acute respiratory tract infections in children (literature review)
by: I. A. Dronov, et al.
Published: (2021-06-01) -
Treatment of bacterial respiratory infections
by: A. D. van Eyk
Published: (2019-04-01) -
Updated guideline for the management of upper respiratory tract infections in South Africa: 2008
by: A.J. Brink
Published: (2009-04-01) -
Treatment of acute respiratory infection in adults: results of a multicenter randomized double-blind placebo-controlled clinical trial
by: M. P. Kostinov, et al.
Published: (2021-06-01)